During his lecture, Prof. Nagler will expand on the latest hematological immunotherapies. New cell-based gene treatments, such as CAR T-cell therapy, and advanced drug conjugated and bispecific monoclonal antibodies, will be discussed.
During his lecture, Prof. Nagler will expand on the latest hematological immunotherapies. New cell-based gene treatments, such as CAR T-cell therapy, and advanced drug conjugated and bispecific monoclonal antibodies, will be discussed.